Zantac and Cancer

• The use of Zantac and other heartburn medications has been linked to various types of cancer.

• The active ingredient in Zantac is a chemical called ranitidine

• Ranitidine breaks down over time and forms NDMA, which is a known human carcinogen 

• The FDA, EPA, and WHO all consider NDMA a cancer-causing chemical

• Zantac has been on the market since the early 1980s 

• Zantac was commonly used to treat heartburn, acid reflux, gastroesphogeal reflux disease (GERD), ulcers, and other conditions

• Zantac was the first drug to generate $1 billion in sales

• On September 13, 2019, the FDA announced an investigation of the link between Zantac use and cancer after Zantac was found to contain NDMA levels up to 3,000 times more than the FDA’s recommended daily limit 

• On April 1, 2020, the FDA pulled Zantac from the market

• Before it was pulled from the market, Zantac was available both by prescription and over the counter

• Several lawsuits have now been filed against the manufacturers of Zantac

• These lawsuits allege that the manufacturers of Zantac concealed the link between Zantac use and cancer

• If you or someone you love was diagnosed with cancer after taking Zantac, you may have a case against Zantac

• Our team of experienced trial attorneys will provide a free consultation and evaluate your case if you reside anywhere in the USA

• The attorneys at Rios Law Firm have handled hundreds of trials, filed lawsuits against several top drug companies, and have decades of combined experience in personal injury law